BiotechTube
Home/AnaCardio/Elin Rosendahl
ER

Elin Rosendahl

Chief Development Officer

AnaCardio

Therapeutic Areas

Cardiovascular DiseaseHeart Failure

AnaCardio Pipeline

DrugIndicationPhase
AC01Heart Failure with Reduced Ejection Fraction (HFrEF)Phase 2

Leadership Team at AnaCardio

LL
Lars Lund
Founder and Chief Scientific Officer
PS
Patrik Strömberg
Chief Executive Officer
View full AnaCardio profile